Brava Diagnostics, Inc. — Form D
Brava Diagnostics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-16. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-16
- Form: D
- Accession: 0001758829-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 1
- Date of first sale: 2018-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326030
Issuer
- Name: Brava Diagnostics, Inc.
- CIK: 0001758829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 5603 ARAPAHOE AVENUE, BOULDER, CO, 80303
- Phone: (661) 993-4085
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert Silverman | Director | Greenville, SC |
| Robert Silverman | Promoter | Greenville, SC |
| David Okrongly | Promoter | New York, NY |
| Chris Myatt | Director | BOULDER, CO |
| Carrie Mulherin | Promoter | Boulder, CO |
| Byron Hewett | Director | Plymouth Meeting, PA |
| Byron Hewett | Executive Officer | Plymouth Meeting, PA |
| Byron Hewett | Promoter | Plymouth Meeting, PA |
Other filings by this issuer (1)
More